NASHVILLE, Tenn., Oct. 15, 2019 /PRNewswire/ -- Tivity Health®, (Nasdaq: TVTY) a leading provider of health improvement solutions, will offer SilverSneakers® members access to more than 16,000 fitness locations nationwide, a variety of programming options in the gym and online as well as activities that promote social connections i

WEST ORANGE, N.J., Oct. 15, 2019 /PRNewswire/ -- More than 3.6 million middle- and high-school students reported using e-cigarettes over the past 30 days (CDC), and 12 percent of teenagers had tried vaping at least once.

MONROVIA, Calif., Oct. 15, 2019 /PRNewswire/ -- Stayhealthy Music announced today that it released its debut single, "The Stay Healthy Shake," distributed through

CLEVELAND, Oct. 15, 2019 /PRNewswire/ -- US healthcare expenditures are forecast to advance 5.2% annually in nominal terms through 2023, according to Healthcare: United States, a report recently released by Freedonia Focus Reports. In real (inflation-adjusted) terms, spending is projected to rise 2.5% annually to 2023. Provi

CHICAGO, Oct. 15, 2019 /PRNewswire/ -- The American Academy of Implant Dentistry (AAID) announced the release of a video focused on educating the public about the life-changing impact of dental implants.

NEW YORK, Oct. 15, 2019 /PRNewswire/ -- The 2019 Nobel Prize in Physiology or Medicine has been awarded jointly to 

SANTA BARBARA, Calif., Oct. 15, 2019 /PRNewswire/ -- Kate Farms® Inc., the leader in plant-based, ready-to-use oral and tube feeding nutrition, announced today at the

DALLAS, Oct. 15, 2019 /PRNewswire/ -- While retail bankruptcies are on the rise since 2017, Dallas-based optical retailer Eyemart Express is thriving with accelerated growth. Eyemart Express currently owns and operates 206 stores in 38 states, ranking among the largest optical retailers in the country. The company plans to increase i

NASHVILLE, Tenn., Oct. 15, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company announces a new publication in Infectious Diseases and Therapy, showing numerically superior cure rates of telavancin compared to vancomycin within a subset of patients who were enrolled in phase 3 ATTAIN trials and had hos

NEW YORK, Oct. 15, 2019 /PRNewswire/ -- Advocates, supporters, healthcare providers, and corporate and community leaders join PCOS Challenge: The